nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.111	0.173	CbGbCtD
Bupropion—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0723	0.112	CbGbCtD
Bupropion—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.063	0.098	CbGbCtD
Bupropion—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0547	0.0851	CbGbCtD
Bupropion—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0456	0.0709	CbGbCtD
Bupropion—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0382	0.0594	CbGbCtD
Bupropion—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0364	0.0567	CbGbCtD
Bupropion—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.031	0.0481	CbGbCtD
Bupropion—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0308	0.0479	CbGbCtD
Bupropion—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0239	0.0371	CbGbCtD
Bupropion—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.023	0.0358	CbGbCtD
Bupropion—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0222	0.0345	CbGbCtD
Bupropion—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0207	0.0323	CbGbCtD
Bupropion—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0178	0.0277	CbGbCtD
Bupropion—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0164	0.0254	CbGbCtD
Bupropion—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0102	0.0159	CbGbCtD
Bupropion—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.01	0.0156	CbGbCtD
Bupropion—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00934	0.0145	CbGbCtD
Bupropion—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00637	0.00991	CbGbCtD
Bupropion—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	8.5e-05	0.000238	CcSEcCtD
Bupropion—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	8.49e-05	0.000238	CcSEcCtD
Bupropion—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000236	CcSEcCtD
Bupropion—Rash—Dactinomycin—peripheral nervous system neoplasm	8.44e-05	0.000236	CcSEcCtD
Bupropion—Decreased appetite—Etoposide—peripheral nervous system neoplasm	8.42e-05	0.000236	CcSEcCtD
Bupropion—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	8.39e-05	0.000235	CcSEcCtD
Bupropion—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	8.36e-05	0.000234	CcSEcCtD
Bupropion—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	8.36e-05	0.000234	CcSEcCtD
Bupropion—Fatigue—Etoposide—peripheral nervous system neoplasm	8.35e-05	0.000234	CcSEcCtD
Bupropion—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	8.35e-05	0.000234	CcSEcCtD
Bupropion—Stomatitis—Epirubicin—peripheral nervous system neoplasm	8.3e-05	0.000232	CcSEcCtD
Bupropion—Jaundice—Epirubicin—peripheral nervous system neoplasm	8.3e-05	0.000232	CcSEcCtD
Bupropion—Pain—Etoposide—peripheral nervous system neoplasm	8.28e-05	0.000232	CcSEcCtD
Bupropion—Constipation—Etoposide—peripheral nervous system neoplasm	8.28e-05	0.000232	CcSEcCtD
Bupropion—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	8.28e-05	0.000232	CcSEcCtD
Bupropion—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	8.28e-05	0.000232	CcSEcCtD
Bupropion—Dysuria—Doxorubicin—peripheral nervous system neoplasm	8.26e-05	0.000231	CcSEcCtD
Bupropion—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.00023	CcSEcCtD
Bupropion—Dizziness—Alitretinoin—peripheral nervous system neoplasm	8.21e-05	0.00023	CcSEcCtD
Bupropion—Diarrhoea—Vincristine—peripheral nervous system neoplasm	8.18e-05	0.000229	CcSEcCtD
Bupropion—Sweating—Epirubicin—peripheral nervous system neoplasm	8.16e-05	0.000229	CcSEcCtD
Bupropion—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	8.16e-05	0.000229	CcSEcCtD
Bupropion—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	8.06e-05	0.000226	CcSEcCtD
Bupropion—Weight increased—Doxorubicin—peripheral nervous system neoplasm	8.04e-05	0.000225	CcSEcCtD
Bupropion—Epistaxis—Epirubicin—peripheral nervous system neoplasm	8.03e-05	0.000225	CcSEcCtD
Bupropion—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	7.99e-05	0.000224	CcSEcCtD
Bupropion—Sinusitis—Epirubicin—peripheral nervous system neoplasm	7.99e-05	0.000224	CcSEcCtD
Bupropion—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	7.98e-05	0.000224	CcSEcCtD
Bupropion—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.000223	CcSEcCtD
Bupropion—Nausea—Dactinomycin—peripheral nervous system neoplasm	7.95e-05	0.000223	CcSEcCtD
Bupropion—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	7.92e-05	0.000222	CcSEcCtD
Bupropion—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	7.92e-05	0.000222	CcSEcCtD
Bupropion—Dizziness—Vincristine—peripheral nervous system neoplasm	7.91e-05	0.000222	CcSEcCtD
Bupropion—Vomiting—Alitretinoin—peripheral nervous system neoplasm	7.89e-05	0.000221	CcSEcCtD
Bupropion—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	7.88e-05	0.000221	CcSEcCtD
Bupropion—Infestation—Doxorubicin—peripheral nervous system neoplasm	7.88e-05	0.000221	CcSEcCtD
Bupropion—Rash—Alitretinoin—peripheral nervous system neoplasm	7.82e-05	0.000219	CcSEcCtD
Bupropion—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	7.82e-05	0.000219	CcSEcCtD
Bupropion—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000219	CcSEcCtD
Bupropion—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	7.79e-05	0.000218	CcSEcCtD
Bupropion—Headache—Alitretinoin—peripheral nervous system neoplasm	7.77e-05	0.000218	CcSEcCtD
Bupropion—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	7.72e-05	0.000216	CcSEcCtD
Bupropion—Urticaria—Etoposide—peripheral nervous system neoplasm	7.7e-05	0.000216	CcSEcCtD
Bupropion—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	7.68e-05	0.000215	CcSEcCtD
Bupropion—Jaundice—Doxorubicin—peripheral nervous system neoplasm	7.68e-05	0.000215	CcSEcCtD
Bupropion—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	7.68e-05	0.000215	CcSEcCtD
Bupropion—Rhinitis—Epirubicin—peripheral nervous system neoplasm	7.66e-05	0.000215	CcSEcCtD
Bupropion—Body temperature increased—Etoposide—peripheral nervous system neoplasm	7.66e-05	0.000215	CcSEcCtD
Bupropion—Abdominal pain—Etoposide—peripheral nervous system neoplasm	7.66e-05	0.000215	CcSEcCtD
Bupropion—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.000215	CcSEcCtD
Bupropion—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.000215	CcSEcCtD
Bupropion—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	7.64e-05	0.000214	CcSEcCtD
Bupropion—Hepatitis—Epirubicin—peripheral nervous system neoplasm	7.64e-05	0.000214	CcSEcCtD
Bupropion—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	7.6e-05	0.000213	CcSEcCtD
Bupropion—Vomiting—Vincristine—peripheral nervous system neoplasm	7.6e-05	0.000213	CcSEcCtD
Bupropion—Asthenia—Cisplatin—peripheral nervous system neoplasm	7.59e-05	0.000213	CcSEcCtD
Bupropion—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	7.59e-05	0.000212	CcSEcCtD
Bupropion—Sweating—Doxorubicin—peripheral nervous system neoplasm	7.55e-05	0.000212	CcSEcCtD
Bupropion—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	7.55e-05	0.000211	CcSEcCtD
Bupropion—Rash—Vincristine—peripheral nervous system neoplasm	7.54e-05	0.000211	CcSEcCtD
Bupropion—Dermatitis—Vincristine—peripheral nervous system neoplasm	7.53e-05	0.000211	CcSEcCtD
Bupropion—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	7.53e-05	0.000211	CcSEcCtD
Bupropion—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	7.51e-05	0.00021	CcSEcCtD
Bupropion—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	7.49e-05	0.00021	CcSEcCtD
Bupropion—Headache—Vincristine—peripheral nervous system neoplasm	7.49e-05	0.00021	CcSEcCtD
Bupropion—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	7.43e-05	0.000208	CcSEcCtD
Bupropion—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	7.39e-05	0.000207	CcSEcCtD
Bupropion—Nausea—Alitretinoin—peripheral nervous system neoplasm	7.37e-05	0.000206	CcSEcCtD
Bupropion—Visual impairment—Epirubicin—peripheral nervous system neoplasm	7.37e-05	0.000206	CcSEcCtD
Bupropion—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	7.23e-05	0.000203	CcSEcCtD
Bupropion—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	7.23e-05	0.000202	CcSEcCtD
Bupropion—Eye disorder—Epirubicin—peripheral nervous system neoplasm	7.14e-05	0.0002	CcSEcCtD
Bupropion—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	7.14e-05	0.0002	CcSEcCtD
Bupropion—Tinnitus—Epirubicin—peripheral nervous system neoplasm	7.13e-05	0.0002	CcSEcCtD
Bupropion—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000199	CcSEcCtD
Bupropion—Nausea—Vincristine—peripheral nervous system neoplasm	7.1e-05	0.000199	CcSEcCtD
Bupropion—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.000199	CcSEcCtD
Bupropion—Flushing—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.000199	CcSEcCtD
Bupropion—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	7.09e-05	0.000199	CcSEcCtD
Bupropion—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	7.07e-05	0.000198	CcSEcCtD
Bupropion—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	7.07e-05	0.000198	CcSEcCtD
Bupropion—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	7.04e-05	0.000197	CcSEcCtD
Bupropion—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.000197	CcSEcCtD
Bupropion—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	6.98e-05	0.000196	CcSEcCtD
Bupropion—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000195	CcSEcCtD
Bupropion—Asthenia—Etoposide—peripheral nervous system neoplasm	6.95e-05	0.000195	CcSEcCtD
Bupropion—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	6.95e-05	0.000195	CcSEcCtD
Bupropion—Angiopathy—Epirubicin—peripheral nervous system neoplasm	6.93e-05	0.000194	CcSEcCtD
Bupropion—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.000194	CcSEcCtD
Bupropion—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	6.9e-05	0.000193	CcSEcCtD
Bupropion—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	6.89e-05	0.000193	CcSEcCtD
Bupropion—Chills—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.000192	CcSEcCtD
Bupropion—Pruritus—Etoposide—peripheral nervous system neoplasm	6.85e-05	0.000192	CcSEcCtD
Bupropion—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	6.83e-05	0.000191	CcSEcCtD
Bupropion—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	6.82e-05	0.000191	CcSEcCtD
Bupropion—Alopecia—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000189	CcSEcCtD
Bupropion—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.72e-05	0.000188	CcSEcCtD
Bupropion—Mental disorder—Epirubicin—peripheral nervous system neoplasm	6.7e-05	0.000188	CcSEcCtD
Bupropion—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	6.69e-05	0.000187	CcSEcCtD
Bupropion—Rash—Cisplatin—peripheral nervous system neoplasm	6.67e-05	0.000187	CcSEcCtD
Bupropion—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.66e-05	0.000187	CcSEcCtD
Bupropion—Malnutrition—Epirubicin—peripheral nervous system neoplasm	6.65e-05	0.000186	CcSEcCtD
Bupropion—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.63e-05	0.000186	CcSEcCtD
Bupropion—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	6.61e-05	0.000185	CcSEcCtD
Bupropion—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	6.59e-05	0.000185	CcSEcCtD
Bupropion—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000184	CcSEcCtD
Bupropion—Flushing—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000184	CcSEcCtD
Bupropion—Flatulence—Epirubicin—peripheral nervous system neoplasm	6.56e-05	0.000184	CcSEcCtD
Bupropion—Tension—Epirubicin—peripheral nervous system neoplasm	6.53e-05	0.000183	CcSEcCtD
Bupropion—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	6.52e-05	0.000183	CcSEcCtD
Bupropion—Nervousness—Epirubicin—peripheral nervous system neoplasm	6.46e-05	0.000181	CcSEcCtD
Bupropion—Back pain—Epirubicin—peripheral nervous system neoplasm	6.44e-05	0.00018	CcSEcCtD
Bupropion—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	6.42e-05	0.00018	CcSEcCtD
Bupropion—Dizziness—Etoposide—peripheral nervous system neoplasm	6.41e-05	0.000179	CcSEcCtD
Bupropion—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	6.4e-05	0.000179	CcSEcCtD
Bupropion—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	6.39e-05	0.000179	CcSEcCtD
Bupropion—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.37e-05	0.000179	CcSEcCtD
Bupropion—Chills—Doxorubicin—peripheral nervous system neoplasm	6.35e-05	0.000178	CcSEcCtD
Bupropion—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	6.32e-05	0.000177	CcSEcCtD
Bupropion—Nausea—Cisplatin—peripheral nervous system neoplasm	6.28e-05	0.000176	CcSEcCtD
Bupropion—Vision blurred—Epirubicin—peripheral nervous system neoplasm	6.27e-05	0.000176	CcSEcCtD
Bupropion—Alopecia—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.000175	CcSEcCtD
Bupropion—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	6.2e-05	0.000174	CcSEcCtD
Bupropion—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6.17e-05	0.000173	CcSEcCtD
Bupropion—Vomiting—Etoposide—peripheral nervous system neoplasm	6.16e-05	0.000173	CcSEcCtD
Bupropion—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	6.16e-05	0.000172	CcSEcCtD
Bupropion—Anaemia—Epirubicin—peripheral nervous system neoplasm	6.15e-05	0.000172	CcSEcCtD
Bupropion—Agitation—Epirubicin—peripheral nervous system neoplasm	6.11e-05	0.000171	CcSEcCtD
Bupropion—Rash—Etoposide—peripheral nervous system neoplasm	6.11e-05	0.000171	CcSEcCtD
Bupropion—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.1e-05	0.000171	CcSEcCtD
Bupropion—Headache—Etoposide—peripheral nervous system neoplasm	6.07e-05	0.00017	CcSEcCtD
Bupropion—Flatulence—Doxorubicin—peripheral nervous system neoplasm	6.07e-05	0.00017	CcSEcCtD
Bupropion—Tension—Doxorubicin—peripheral nervous system neoplasm	6.04e-05	0.000169	CcSEcCtD
Bupropion—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	6.03e-05	0.000169	CcSEcCtD
Bupropion—Malaise—Epirubicin—peripheral nervous system neoplasm	6e-05	0.000168	CcSEcCtD
Bupropion—Nervousness—Doxorubicin—peripheral nervous system neoplasm	5.98e-05	0.000167	CcSEcCtD
Bupropion—Vertigo—Epirubicin—peripheral nervous system neoplasm	5.98e-05	0.000167	CcSEcCtD
Bupropion—Syncope—Epirubicin—peripheral nervous system neoplasm	5.97e-05	0.000167	CcSEcCtD
Bupropion—Leukopenia—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.000167	CcSEcCtD
Bupropion—Back pain—Doxorubicin—peripheral nervous system neoplasm	5.95e-05	0.000167	CcSEcCtD
Bupropion—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	5.92e-05	0.000166	CcSEcCtD
Bupropion—Palpitations—Epirubicin—peripheral nervous system neoplasm	5.88e-05	0.000165	CcSEcCtD
Bupropion—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	5.85e-05	0.000164	CcSEcCtD
Bupropion—Cough—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.000163	CcSEcCtD
Bupropion—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	5.8e-05	0.000163	CcSEcCtD
Bupropion—Convulsion—Epirubicin—peripheral nervous system neoplasm	5.76e-05	0.000161	CcSEcCtD
Bupropion—Nausea—Etoposide—peripheral nervous system neoplasm	5.75e-05	0.000161	CcSEcCtD
Bupropion—Hypertension—Epirubicin—peripheral nervous system neoplasm	5.74e-05	0.000161	CcSEcCtD
Bupropion—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5.71e-05	0.00016	CcSEcCtD
Bupropion—Anaemia—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.000159	CcSEcCtD
Bupropion—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.66e-05	0.000159	CcSEcCtD
Bupropion—Arthralgia—Epirubicin—peripheral nervous system neoplasm	5.66e-05	0.000159	CcSEcCtD
Bupropion—Chest pain—Epirubicin—peripheral nervous system neoplasm	5.66e-05	0.000159	CcSEcCtD
Bupropion—Agitation—Doxorubicin—peripheral nervous system neoplasm	5.66e-05	0.000158	CcSEcCtD
Bupropion—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.64e-05	0.000158	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.000158	CcSEcCtD
Bupropion—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.6e-05	0.000157	CcSEcCtD
Bupropion—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.55e-05	0.000156	CcSEcCtD
Bupropion—Dry mouth—Epirubicin—peripheral nervous system neoplasm	5.54e-05	0.000155	CcSEcCtD
Bupropion—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000155	CcSEcCtD
Bupropion—Syncope—Doxorubicin—peripheral nervous system neoplasm	5.52e-05	0.000155	CcSEcCtD
Bupropion—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	5.51e-05	0.000154	CcSEcCtD
Bupropion—Confusional state—Epirubicin—peripheral nervous system neoplasm	5.48e-05	0.000153	CcSEcCtD
Bupropion—Palpitations—Doxorubicin—peripheral nervous system neoplasm	5.44e-05	0.000152	CcSEcCtD
Bupropion—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	5.43e-05	0.000152	CcSEcCtD
Bupropion—Oedema—Epirubicin—peripheral nervous system neoplasm	5.43e-05	0.000152	CcSEcCtD
Bupropion—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	5.41e-05	0.000152	CcSEcCtD
Bupropion—Infection—Epirubicin—peripheral nervous system neoplasm	5.39e-05	0.000151	CcSEcCtD
Bupropion—Cough—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.00015	CcSEcCtD
Bupropion—Shock—Epirubicin—peripheral nervous system neoplasm	5.34e-05	0.00015	CcSEcCtD
Bupropion—Convulsion—Doxorubicin—peripheral nervous system neoplasm	5.33e-05	0.000149	CcSEcCtD
Bupropion—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	5.33e-05	0.000149	CcSEcCtD
Bupropion—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	5.32e-05	0.000149	CcSEcCtD
Bupropion—Hypertension—Doxorubicin—peripheral nervous system neoplasm	5.32e-05	0.000149	CcSEcCtD
Bupropion—Tachycardia—Epirubicin—peripheral nervous system neoplasm	5.3e-05	0.000148	CcSEcCtD
Bupropion—Skin disorder—Epirubicin—peripheral nervous system neoplasm	5.27e-05	0.000148	CcSEcCtD
Bupropion—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.000147	CcSEcCtD
Bupropion—Chest pain—Doxorubicin—peripheral nervous system neoplasm	5.24e-05	0.000147	CcSEcCtD
Bupropion—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	5.24e-05	0.000147	CcSEcCtD
Bupropion—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.24e-05	0.000147	CcSEcCtD
Bupropion—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.22e-05	0.000146	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000146	CcSEcCtD
Bupropion—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.18e-05	0.000145	CcSEcCtD
Bupropion—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.18e-05	0.000145	CcSEcCtD
Bupropion—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	5.13e-05	0.000144	CcSEcCtD
Bupropion—Hypotension—Epirubicin—peripheral nervous system neoplasm	5.07e-05	0.000142	CcSEcCtD
Bupropion—Confusional state—Doxorubicin—peripheral nervous system neoplasm	5.07e-05	0.000142	CcSEcCtD
Bupropion—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.02e-05	0.000141	CcSEcCtD
Bupropion—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.02e-05	0.000141	CcSEcCtD
Bupropion—Infection—Doxorubicin—peripheral nervous system neoplasm	4.99e-05	0.00014	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.95e-05	0.000139	CcSEcCtD
Bupropion—Shock—Doxorubicin—peripheral nervous system neoplasm	4.94e-05	0.000138	CcSEcCtD
Bupropion—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.000138	CcSEcCtD
Bupropion—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.92e-05	0.000138	CcSEcCtD
Bupropion—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.91e-05	0.000138	CcSEcCtD
Bupropion—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	4.9e-05	0.000137	CcSEcCtD
Bupropion—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	4.88e-05	0.000137	CcSEcCtD
Bupropion—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.88e-05	0.000137	CcSEcCtD
Bupropion—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.86e-05	0.000136	CcSEcCtD
Bupropion—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.84e-05	0.000136	CcSEcCtD
Bupropion—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.000135	CcSEcCtD
Bupropion—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.000134	CcSEcCtD
Bupropion—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.78e-05	0.000134	CcSEcCtD
Bupropion—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.72e-05	0.000132	CcSEcCtD
Bupropion—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.69e-05	0.000132	CcSEcCtD
Bupropion—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.69e-05	0.000131	CcSEcCtD
Bupropion—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.68e-05	0.000131	CcSEcCtD
Bupropion—Pain—Epirubicin—peripheral nervous system neoplasm	4.64e-05	0.00013	CcSEcCtD
Bupropion—Constipation—Epirubicin—peripheral nervous system neoplasm	4.64e-05	0.00013	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.000128	CcSEcCtD
Bupropion—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.54e-05	0.000127	CcSEcCtD
Bupropion—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.000126	CcSEcCtD
Bupropion—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000125	CcSEcCtD
Bupropion—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.47e-05	0.000125	CcSEcCtD
Bupropion—Somnolence—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000125	CcSEcCtD
Bupropion—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.44e-05	0.000124	CcSEcCtD
Bupropion—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	0.000124	CcSEcCtD
Bupropion—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000122	CcSEcCtD
Bupropion—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.34e-05	0.000122	CcSEcCtD
Bupropion—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.33e-05	0.000121	CcSEcCtD
Bupropion—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.31e-05	0.000121	CcSEcCtD
Bupropion—Pain—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.00012	CcSEcCtD
Bupropion—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.00012	CcSEcCtD
Bupropion—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.29e-05	0.00012	CcSEcCtD
Bupropion—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.29e-05	0.00012	CcSEcCtD
Bupropion—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.14e-05	0.000116	CcSEcCtD
Bupropion—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.11e-05	0.000115	CcSEcCtD
Bupropion—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4e-05	0.000112	CcSEcCtD
Bupropion—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000112	CcSEcCtD
Bupropion—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.97e-05	0.000111	CcSEcCtD
Bupropion—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.97e-05	0.000111	CcSEcCtD
Bupropion—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.000109	CcSEcCtD
Bupropion—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.84e-05	0.000108	CcSEcCtD
Bupropion—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.72e-05	0.000104	CcSEcCtD
Bupropion—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000104	CcSEcCtD
Bupropion—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.6e-05	0.000101	CcSEcCtD
Bupropion—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.59e-05	0.000101	CcSEcCtD
Bupropion—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.55e-05	9.96e-05	CcSEcCtD
Bupropion—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.45e-05	9.67e-05	CcSEcCtD
Bupropion—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.44e-05	9.63e-05	CcSEcCtD
Bupropion—Rash—Epirubicin—peripheral nervous system neoplasm	3.42e-05	9.59e-05	CcSEcCtD
Bupropion—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.42e-05	9.58e-05	CcSEcCtD
Bupropion—Headache—Epirubicin—peripheral nervous system neoplasm	3.4e-05	9.53e-05	CcSEcCtD
Bupropion—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.32e-05	9.31e-05	CcSEcCtD
Bupropion—Nausea—Epirubicin—peripheral nervous system neoplasm	3.23e-05	9.04e-05	CcSEcCtD
Bupropion—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.19e-05	8.95e-05	CcSEcCtD
Bupropion—Rash—Doxorubicin—peripheral nervous system neoplasm	3.17e-05	8.87e-05	CcSEcCtD
Bupropion—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.16e-05	8.87e-05	CcSEcCtD
Bupropion—Headache—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	8.82e-05	CcSEcCtD
Bupropion—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.98e-05	8.36e-05	CcSEcCtD
